Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
1970-01-01 08:00
Ex-Pfizer Employee Charged With Illegal Trades on Paxlovid Trial
A former Pfizer Inc. employee was charged with using inside information about the company’s Covid-19 treatment Paxlovid to
1970-01-01 08:00
Ipsen Gets FDA Advisers’ Backing for Rare Bone Disease Drug
Ipsen SA’s drug for a rare bone disease got support from a panel of US drug regulatory advisers,
1970-01-01 08:00
The Race to Develop Weight-Loss Pills Has Some Drugmakers Falling Behind
Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs
1970-01-01 08:00
Sunak Pledges 15-Year NHS Training Plan With Record Waiting Lists
Prime Minister Rishi Sunak is proposing the biggest training expansion in the history of the UK’s National Health
1970-01-01 08:00
Nurses Have Had Enough, Threatening Big Gaps in US Health Care
A large swath of American nurses want out of the profession, raising the threat of a mass exodus
1970-01-01 08:00
Covid-19 Origins Remain a Mystery, Declassified Report Shows
US intelligence agencies weren’t able to determine whether researchers at laboratory in Wuhan, China, who fell sick in
1970-01-01 08:00
Eli Lilly’s Experimental Weight-Loss Pill Show Rapid Results in Study
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the
1970-01-01 08:00
Pfizer, GSK Shots for RSV Get Backing for Older Adults
Shots from Pfizer Inc. and GSK Plc that prevent respiratory syncytial virus got backing from a panel of
1970-01-01 08:00
Biden To Formally Tap Mandy Cohen For CDC Director Imminently
President Joe Biden said he intends to appoint former North Carolina health chief Mandy Cohen as the next
1970-01-01 08:00
Carson Block’s Latest Short Bet Is Burned by Novartis M&A Deal
Carson Block’s Muddy Waters wager against a hedge-fund favorite, Chinook Therapeutics Inc., took a hit Monday after Novartis
1970-01-01 08:00
Illumina CEO DeSouza Resigns After Facing Pressure From Icahn
Illumina Inc.’s board accepted the resignation of Chief Executive Officer Francis deSouza, effective Sunday, according to a statement.
1970-01-01 08:00